Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Pain Medicine (Malden, Mass.)
|
April 8, 2014
Spanish translation and linguistic validation of the screener and opioid assessment for patients with pain-revised (SOAPP-R)
Armando Villarreal, John Markman
Neuromodulation : Journal of the International Neuromodulation Society
|
November 15, 2014
Medical management of chronic low back pain: efficacy and outcomes
Lynn R Webster, John Markman
Neurology. Clinical Practice
|
February 24, 2018
Spinal pain: When is it time for an intervention?
Gary M Franklin, John Markman
Postgraduate Medicine
|
December 6, 2016
Current and future development of extended-release, abuse-deterrent opioid formulations in the United States
Lynn R Webster, John Markman, Edward J Cone, et al.
Pain
|
December 1, 2025
Clinical phenotype matters: structural and functional thalamic changes in neuropathic low-back pain
Ruiyi Yuan, Martin Cole, Jennifer Gewandter, et al.
Journal of Diabetes and Its Complications
|
December 16, 2014
Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy
Alesia Sadosky, Jack Mardekian, Bruce Parsons, et al.
Pain Management
|
September 26, 2024
Multidevice spinal cord stimulation trials: shared decision making in the era of multiple neuromodulation paradigms
Soun Sheen, John Markman, Michael Sohn, et al.
Cutis
|
April 7, 2015
Trigeminal trophic syndrome with histopathologic correlation
Lindsey B Dolohanty, Steven J Richardson, David N Herrmann, et al.
Pain Medicine (Malden, Mass.)
|
June 3, 2016
Using Random Forest Models to Identify Correlates of a Diabetic Peripheral Neuropathy Diagnosis from Electronic Health Record Data
Sarah DuBrava, Jack Mardekian, Alesia Sadosky, et al.
Journal of Pain Research
|
October 6, 2018
Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone
John Markman, Diana S Meske, Ernest A Kopecky, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Pain Medicine (Malden, Mass.)
|
April 8, 2014
Spanish translation and linguistic validation of the screener and opioid assessment for patients with pain-revised (SOAPP-R)
Armando Villarreal, John Markman
Neuromodulation : Journal of the International Neuromodulation Society
|
November 15, 2014
Medical management of chronic low back pain: efficacy and outcomes
Lynn R Webster, John Markman
Neurology. Clinical Practice
|
February 24, 2018
Spinal pain: When is it time for an intervention?
Gary M Franklin, John Markman
Postgraduate Medicine
|
December 6, 2016
Current and future development of extended-release, abuse-deterrent opioid formulations in the United States
Lynn R Webster, John Markman, Edward J Cone, et al.
Pain
|
December 1, 2025
Clinical phenotype matters: structural and functional thalamic changes in neuropathic low-back pain
Ruiyi Yuan, Martin Cole, Jennifer Gewandter, et al.
Journal of Diabetes and Its Complications
|
December 16, 2014
Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy
Alesia Sadosky, Jack Mardekian, Bruce Parsons, et al.
Pain Management
|
September 26, 2024
Multidevice spinal cord stimulation trials: shared decision making in the era of multiple neuromodulation paradigms
Soun Sheen, John Markman, Michael Sohn, et al.
Cutis
|
April 7, 2015
Trigeminal trophic syndrome with histopathologic correlation
Lindsey B Dolohanty, Steven J Richardson, David N Herrmann, et al.
Pain Medicine (Malden, Mass.)
|
June 3, 2016
Using Random Forest Models to Identify Correlates of a Diabetic Peripheral Neuropathy Diagnosis from Electronic Health Record Data
Sarah DuBrava, Jack Mardekian, Alesia Sadosky, et al.
Journal of Pain Research
|
October 6, 2018
Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone
John Markman, Diana S Meske, Ernest A Kopecky, et al.
Page
of 3